Status:
COMPLETED
Thrombophylaxis in Transurethral Surgery With Dalteparine
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Thrombophylaxis in Transurethral Surgery
Eligibility:
All Genders
Phase:
NA
Brief Summary
The rationale for thrombophrophylaxis is well known. Without prophylaxis the incidence of objectivlely confirmed, hospital-acquired deep venous thrombosis is approximately 10% to 40% among medical or ...
Detailed Description
The aim of our study is to proof that transurethral surgery under thrombophylaxis with dalteparine is safe. The study design is double-blind placebo controlled.
Eligibility Criteria
Inclusion
- transurethral surgery
Exclusion
- oral anticoagulation
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00681785
Start Date
June 1 2006
End Date
December 1 2007
Last Update
May 21 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urologische Universitätsklinik beider Basel
Liestal, Switzerland, 4410